Previous Article | Next Article ![]()
J. Virol., Dec 1997, 9143-9149, Vol 71, No. 12
E Mendez, T Kawanishi, K Clemens, H Siomi, SS Soldan, P Calabresi, J Brady and S Jacobson
Human T-cell lymphotropic virus type 1 (HTLV-1) is associated with a
chronic neurological disease termed HTLV-1-associated myelopathy/tropical
spastic paraperesis (HAM/TSP). Although the pathogenesis of this disease
remains to be elucidated, the evidence suggests that immunopathological
mechanisms are involved. Since HTLV-1 tax mRNA was colocalized with glial
acidic fibrillary protein, a marker for astrocytes, we developed an in
vitro model to assess whether HTLV-1 infection activates astrocytes to
secrete cytokines or present viral immunodominant epitopes to
virus-specific T cells. Two human astrocytic glioma cell lines, U251 and
U373, were transfected with the 3' portion of the HTLV-1 genome and with
the HTLV-1 tax gene under astrocyte- specific promoter control. In this
study, we report that Tax-expressing astrocytic glioma transfectants
activate the expression of tumor necrosis factor alpha mRNA in vitro.
Furthermore, these Tax-expressing glioma transfectants can serve as
immunological targets for HTLV-1- specific cytotoxic T lymphocytes (CTL).
We propose that these events could contribute to the neuropathology of
HAM/TSP, since infected astrocytes can become a source for inflammatory
cytokines upon HTLV-1 infection and serve as targets for HTLV-1-specific
CTL, resulting in parenchymal damage by direct lysis and/or cytokine
release.
Copyright © 1997, American Society for Microbiology
Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells
Neuroimmunology Branch, National Institute of Neurologic Diseases and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|